CAS: 173937-91-2 - Atrasentan
Formula:C29H39ClN2O6
InChI:InChI=1S/C29H38N2O6/c1-4-6-14-30(15-7-5-2)26(32)18-31-17-23(21-10-13-24-25(16-21)37-19-36-24)27(29(33)34)28(31)20-8-11-22(35-3)12-9-20/h8-13,16,23,27-28H,4-7,14-15,17-19H2,1-3H3,(H,33,34)/t23-,27-,28+/m1/s1
InChI key:InChIKey=MOTJMGVDPWRKOC-QPVYNBJUSA-N
SMILES:O=C(O)C1C(C2=CC=C(OC)C=C2)N(CC(=O)N(CCCC)CCCC)CC1C3=CC=C4OCOC4=C3
- Synonyms:
- (+)-A 127722
- (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic acid
- (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid
- (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride (1:1)
- 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-, (2R,3R,4S)-
- 3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-, [2R-(2α,3β,4α)]-
- A 147627
- Abt 627
- Altrasentan
3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-, (2R,3R,4S)-
Ref: AN-AG001ZB3
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Atrasentan
Ref: TM-TQ0259
1mg | 48.00 € | |
5mg | 94.00 € | |
10mg | 134.00 € | |
25mg | 260.00 € | |
50mg | To inquire | |
1ml*10 (DMSO) | 119.00 € |
Atrasentan
Controlled ProductRef: TR-A793925
5mg | 391.00 € |
Atrasentan
Ref: 3D-FA29947
1g | To inquire |